High Tech Pharm Co., Ltd. (KOSDAQ: 106190)

High Tech Pharm Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 14, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	165,771	99,208	77,268	97,116	130,788	80,103
Market Cap Growth	23.01%	28.39%	-20.44%	-25.75%	63.27%	-35.06%
Enterprise Value	170,535	111,271	89,346	110,402	138,335	84,658
Last Close Price	15590.00	9330.00	7216.48	9013.06	12093.72	7383.99
PE Ratio	7.58	8.19	13.07	-	-	-
PS Ratio	1.35	1.29	0.75	1.33	1.76	1.27
PB Ratio	1.43	0.93	0.77	1.03	1.37	0.81
P/TBV Ratio	1.20	0.93	0.77	1.03	1.37	0.81
P/FCF Ratio	19.03	-	-	16.00	-	245.20
P/OCF Ratio	12.46	34.11	-	14.02	-	32.25
EV/Sales Ratio	2.09	1.45	0.87	1.51	1.86	1.34
EV/EBITDA Ratio	7.20	7.38	8.53	21.49	64.99	86.55
EV/EBIT Ratio	9.18	11.03	18.13	-	-	-
EV/FCF Ratio	19.58	-	-	18.19	-	259.14
Debt / Equity Ratio	0.11	0.15	0.16	0.17	0.11	0.11
Debt / EBITDA Ratio	0.53	1.09	1.57	3.11	4.92	11.05
Debt / FCF Ratio	1.45	-	-	2.63	-	33.09
Asset Turnover	0.60	0.57	0.81	0.58	0.57	0.48
Inventory Turnover	1.90	3.18	5.88	3.86	5.13	6.26
Quick Ratio	1.19	1.31	1.15	0.97	0.77	1.09
Current Ratio	2.82	2.48	1.64	1.78	1.50	1.53
Return on Equity (ROE)	13.28%	7.81%	6.06%	-1.30%	-3.25%	-4.18%
Return on Assets (ROA)	8.51%	4.72%	2.41%	-0.20%	-1.60%	-2.14%
Return on Capital (ROIC)	9.33%	5.26%	2.72%	-0.24%	-1.93%	-2.57%
Earnings Yield	13.19%	8.14%	7.60%	-1.26%	-2.41%	-5.27%
FCF Yield	5.26%	-2.20%	-5.64%	6.25%	-6.60%	0.41%
Payout Ratio	4.87%	6.14%	6.04%	-	-	-
Buyback Yield / Dilution	33.56%	33.37%	-0.14%	0.00%	0.08%	-0.01%
Total Shareholder Return	34.20%	33.37%	-0.14%	0.00%	0.08%	-0.01%

Source: S&P Capital IQ. Standard template. Financial Sources.